Taken together, we hypothesized that antagonizing ZDHHC5-mediated palmitoylation on the cytoplasmic tail of SSTR5 may represent a more efficacious approach for the treatment of pancreatic cancer. The gene discussed is SSTR5; the disease is familial pancreatic carcinoma.